A detailed history of Cooper Financial Group transactions in Johnson & Johnson stock. As of the latest transaction made, Cooper Financial Group holds 9,691 shares of JNJ stock, worth $1.6 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares
9,691
Previous 9,682 0.09%
Holding current value
$1.6 Million
Previous $1.53 Million 7.51%
% of portfolio
0.21%
Previous 0.25%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 15, 2024

BUY
$144.38 - $157.78 $1,299 - $1,420
9 Added 0.09%
9,691 $1.42 Million
Q1 2024

Apr 11, 2024

BUY
$155.22 - $162.74 $19,557 - $20,505
126 Added 1.32%
9,682 $1.53 Million
Q4 2023

Jan 16, 2024

BUY
$145.6 - $158.88 $40,768 - $44,486
280 Added 3.02%
9,556 $1.5 Million
Q3 2023

Oct 13, 2023

SELL
$155.75 - $174.48 $67,751 - $75,898
-435 Reduced 4.48%
9,276 $1.44 Million
Q2 2023

Jul 07, 2023

SELL
$154.35 - $166.11 $38,124 - $41,029
-247 Reduced 2.48%
9,711 $1.61 Million
Q1 2023

May 10, 2023

SELL
$151.05 - $180.26 $4,229 - $5,047
-28 Reduced 0.28%
9,958 $1.54 Million
Q4 2022

Jan 13, 2023

BUY
$160.2 - $179.79 $46,618 - $52,318
291 Added 3.0%
9,986 $0
Q3 2022

Oct 13, 2022

SELL
$161.33 - $179.52 $96,152 - $106,993
-596 Reduced 5.79%
9,695 $1.58 Million
Q2 2022

Jul 11, 2022

BUY
$168.19 - $186.01 $135,729 - $150,110
807 Added 8.51%
10,291 $1.83 Million
Q1 2022

Apr 12, 2022

BUY
$158.14 - $179.59 $73,693 - $83,688
466 Added 5.17%
9,484 $1.68 Million
Q4 2021

Feb 11, 2022

SELL
$155.93 - $173.01 $124,899 - $138,581
-801 Reduced 8.16%
9,018 $1.54 Million
Q3 2021

Oct 06, 2021

SELL
$161.5 - $179.47 $10,013 - $11,127
-62 Reduced 0.63%
9,819 $1.59 Million
Q2 2021

Jul 12, 2021

SELL
$159.48 - $171.07 $206,048 - $221,022
-1,292 Reduced 11.56%
9,881 $1.63 Million
Q1 2021

May 17, 2021

SELL
$153.07 - $170.48 $155,366 - $173,037
-1,015 Reduced 8.33%
11,173 $1.84 Million
Q4 2020

Feb 16, 2021

BUY
$137.11 - $157.38 $362,518 - $416,112
2,644 Added 27.7%
12,188 $1.92 Million
Q3 2020

Oct 09, 2020

SELL
$140.38 - $153.83 $4,632 - $5,076
-33 Reduced 0.34%
9,544 $1.42 Million
Q2 2020

Jul 15, 2020

BUY
$128.81 - $155.51 $93,644 - $113,055
727 Added 8.21%
9,577 $1.35 Million
Q1 2020

May 15, 2020

BUY
$111.14 - $153.99 $247,286 - $342,627
2,225 Added 33.58%
8,850 $1.16 Million
Q4 2019

Jan 07, 2020

SELL
$127.5 - $146.44 $27,285 - $31,338
-214 Reduced 3.13%
6,625 $966,000
Q3 2019

Oct 08, 2019

SELL
$126.95 - $142.14 $13,202 - $14,782
-104 Reduced 1.5%
6,839 $885,000
Q2 2019

Jul 08, 2019

BUY
$131.15 - $144.24 $186,626 - $205,253
1,423 Added 25.78%
6,943 $967,000
Q1 2019

May 15, 2019

BUY
$125.72 - $139.79 $8,297 - $9,226
66 Added 1.21%
5,520 $772,000
Q4 2018

Jan 17, 2019

BUY
$122.84 - $147.84 $669,969 - $806,319
5,454 New
5,454 $704,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $431B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Cooper Financial Group Portfolio

Follow Cooper Financial Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cooper Financial Group, based on Form 13F filings with the SEC.

News

Stay updated on Cooper Financial Group with notifications on news.